Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01255748 · ClinicalTrials.gov registry record
Registry Study for Radiation Therapy Outcomes
A clinical trial of Neoplasms, sponsored by Proton Collaborative Group.
- Recruiting
- Registry status
- 40,000
- Enrollment target
- 20
- Study locations
NCT01255748 is a study of Neoplasms that is actively recruiting participants, run by Proton Collaborative Group. The registered enrollment target is 40,000 participants, above the 1,368-participant average among 158 other Neoplasms trials with a reported enrollment target (2824% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT01255748, a study of Neoplasms, is actively recruiting participants, sponsored by Proton Collaborative Group.
- RECRUITING
- Registry status
- 40,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.
Conditions Studied
Interventions
- RADIATION Proton Therapy, Photon Therapy, SRS, Brachytherapy
Study Locations (20)
Florida
- South Florida Proton Therapy Institute - Delray Beach
- Ackerman Cancer Center - Jacksonville
- Dwoskin Proton Therapy Center - Miami
- Miami Cancer Institute - Miami
- Orlando Health Cancer Institute - Orlando
Illinois
- OSF HealthCare Cancer Institute - Peoria
- Northwestern Medicine Chicago Proton Center - Warrenville
Kansas
- University of Kansas Proton Therapy Center - Kansas City
- Kansas City Proton Institute - Overland Park
Missouri
- Washington University in St. Louis - St Louis
- Mercy David C. Pratt Cancer Center - St Louis
Arizona
- Mayo Clinic - Scottsdale
Arkansas
- Proton Center of Arkansas - Little Rock
California
- California Protons Cancer Therapy Center - San Diego
Georgia
- Emory Proton Therapy Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,000 participants |
| Start Date | 2009-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01255748
The ClinicalTrials.gov registry entry for NCT01255748 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,368-participant average among 158 other Neoplasms trials with a reported enrollment target (2824% higher). The listed sponsor is Proton Collaborative Group, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Proton Therapy, Photon Therapy, SRS, Brachytherapy is the first listed.
NCT01255748 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Illinois, Kansas.
Frequently Asked Questions
What is clinical trial NCT01255748 about?
NCT01255748 is a clinical study titled "Registry Study for Radiation Therapy Outcomes". The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.
What is the current status of trial NCT01255748?
This trial is currently recruiting. The enrollment target is 40,000 participants. The study started on 2009-06.
What conditions does trial NCT01255748 study?
This clinical trial studies the following conditions: Neoplasms.
What interventions are being tested in trial NCT01255748?
The interventions under investigation include: Proton Therapy, Photon Therapy, SRS, Brachytherapy (RADIATION).
Who is sponsoring clinical trial NCT01255748?
This trial is sponsored by Proton Collaborative Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01255748 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RECRUITING · Phase 1
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
RECRUITING · Phase 1
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
RECRUITING · Phase 1
-
Resilience in East Asian Immigrants for Advance Care Planning Discussions
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.